Trial intelligence / Profile preview

Effect of Coagulation Factor Concentrates vs FFP/Cryoprecipitate in High-Bleeding-Risk Non-Cardiac Surgery

KCT0011445Phase 4Not yet recruiting

Sponsor
Ministry of Health & Welfare
Start
Jan 2026
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of prothrombin complex concentrate, human and Fibrinogen human in coagulopathy and perioperative bleeding (2 arms), sponsored by Ministry of Health & Welfare. Primary endpoints: Intraoperative coagulation function and Effectiveness in treatment of intraoperative coagulopathy. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

prothrombin complex concentrate, humanFibrinogen human
03

Conditions

coagulopathyperioperative bleeding

Beyond the preview

Go deeper on KCT0011445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0011445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call